We are a fast-growing biotech on a mission to develop much-needed new medicines for cancer and fibrosis. Our carefully chosen team values collaboration, hard work and shares the belief that anti-Claudin-1 therapies will make a difference for patients.
We are always looking for motivated talent across the healthcare, life science, pharmaceutical and biotechnology sectors. Are you qualified to help us achieve our mission? Check out the job openings below.
Transforming lives
Alentis was founded on ground-breaking research in the laboratory of Prof. Thomas Baumert, MD at the University of Strasbourg and French National Institute of Health and Medical Research (Inserm). With the discovery of a therapeutic antibody against Claudin-1, Prof. Baumert paved the way for new therapies to transform the lives of patients.
Striving for excellence
Since our inception in 2019, we successfully and rapidly expanded Alentis and our pipeline of novel antibodies. This growth is a testament to the collective expertise and skill of our team.
We are a science-driven organization where trust, fast decision making and a profoundly supportive environment enable us to reach our ambitious goals.